Master Hypovolemia Now!

Boost your patient care skills.
Learn more
Learn more
Hypovolemia

Hypovolemia

Medically reviewed by:
Last updated:
April 15, 2026

Table of Contents

What is Hypovolemia?

Hypovolemia is a reduction in extracellular fluid volume, usually due to loss of sodium-containing fluid such as blood, gastrointestinal losses, renal losses, skin losses, or third-space sequestration. When significant, hypovolemia reduces venous return and tissue perfusion and can progress to hypotension or hypovolemic shock.

Early recognition is important because compensated volume depletion can deteriorate to organ hypoperfusion and shock if the deficit persists. While the body initially uses compensatory mechanisms to maintain blood pressure, these defenses can eventually fail. Clinicians prioritize hypovolemia assessment in emergency settings to prevent progression to multi-organ failure.

What causes Hypovolemia?

Acute hypovolemia develops when sodium and water losses are not adequately replaced or when fluid shifts into a third space outside the effective circulation. Common causes include hemorrhage, persistent vomiting, diarrhea, and extensive burns. The cause of hypovolemia may also involve renal sodium and water losses from diuretics, osmotic diuresis due to hyperglycemia, hypoaldosteronism or other salt-wasting states, and third-space sequestration.

Pathophysiologically, reduced preload lowers stroke volume, the amount of blood pumped with each heartbeat. This drop in cardiac output stimulates a surge in sympathetic tone, which may briefly sustain blood pressure but eventually compromises organ perfusion if the deficit persists. Older adults are especially vulnerable because they have lower total body water and may have impaired thirst, reduced access to fluids, or limited physiologic reserve.

What are the signs and symptoms of Hypovolemia?

The symptoms of hypovolemia typically include dizziness, intense thirst, and altered mentation (confusion), reflecting cerebral hypoperfusion. Objective signs of hypovolemia include tachycardia, a narrowed pulse pressure, cool extremities, and oliguria, or low urine output. Clinicians may also observe delayed capillary refill and decreased skin turgor, though flattened neck veins may be difficult to assess in individuals on mechanical ventilation.

As cardiac output continues to fall, compensatory tachycardia is often the earliest clinical clue. Left untreated, prolonged hypotension leads to lactic acidosis and obtundation (decreased alertness). Differentiating these findings from hypervolemia signs and symptoms (such as pulmonary edema, elevated jugular venous pressure, and peripheral swelling) is essential to preventing fluid overload.

How is Hypovolemia diagnosed?

Effective hypovolemia identification is primarily clinical, supported by the history, physical examination, and selected laboratory findings. Clinicians narrow down the cause by identifying a history of bleeding or fluid loss alongside physical findings, while laboratory tests such as serum electrolytes, BUN and creatinine, and lactate may support the assessment. Elevated lactate levels further indicate inadequate tissue perfusion and anaerobic metabolism.

A bedside ultrasound of the inferior vena cava may augment the physical examination, but it does not reliably predict fluid responsiveness in all patients. Central venous pressure is a limited marker of volume responsiveness, and dynamic measures such as passive leg raise are generally more informative in appropriate settings. Orthostatic symptoms or postural hypotension can support the diagnosis.

How is Hypovolemia treated?

The primary goal of hypovolemia treatment is the rapid restoration of circulating volume using isotonic crystalloids, such as 0.9% sodium chloride or balanced electrolyte solutions. These are typically administered in boluses of 500 to 1,000 mL, with the clinical team reassessing the individual after each infusion. In hemorrhagic hypovolemia, prompt control of bleeding and early blood product resuscitation are priorities, with crystalloids used mainly as a bridge while blood products are being prepared.

If hypotension persists after adequate volume replacement, vasopressors may be used temporarily in refractory shock while the underlying cause is being corrected. Response to treatment should be guided by repeated assessment of blood pressure, mental status, urine output, lactate, and signs of fluid overload.

What are the most important facts to know about Hypovolemia?

  • Hypovolemia is a reduction in extracellular fluid volume, most often caused by loss of sodium-containing fluid from bleeding, the gastrointestinal tract, kidneys, skin, or third-space sequestration.
  • The reduction in preload activates compensatory vasoconstriction, which can mask the severity of the deficit in its early stages.
  • Common signs of hypovolemia include tachycardia and oliguria, while symptoms of hypovolemia often manifest as dizziness and confusion.
  • Hypovolemia identification is primarily clinical, though laboratory findings and bedside ultrasound may support the assessment.
  • Treatment prioritizes isotonic crystalloid boluses and blood products, with vasopressors reserved for refractory hypotension.

References

  1. Cleveland Clinic. (2022, May 12). Hypovolemia. https://my.clevelandclinic.org/health/diseases/22963-hypovolemia
  2. Lewis, J. L., III. (2024, May). Volume depletion. Merck Manual Professional Edition. https://www.merckmanuals.com/professional/nephrology/fluid-metabolism/volume-depletion
  3. National Institute for Health and Care Excellence. (2017, May 5). Intravenous fluid therapy in adults in hospital (Clinical guideline CG174). https://www.nice.org.uk/guidance/cg174
  4. Taghavi, S., Nassar, A. K., & Askari, R. (2025, June 1). Hypovolemia and hypovolemic shock. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513297/

User Reviews